Ironwood Pharmaceuticals (IRWD) Cost of Revenue (2013 - 2020)

Ironwood Pharmaceuticals has disclosed Cost of Revenue across 7 years of filings, most recently posting $897000.0 for Q4 2020.

• In Q4 2020, Cost of Revenue fell 91.86% year-over-year to $897000.0; the TTM figure through Dec 2020 stood at $3.1 million (down 86.86% YoY), while the FY2020 annual figure was $3.1 million, down 86.86% from the prior year.
• Cost of Revenue came in at $897000.0 for Q4 2020 at Ironwood Pharmaceuticals, down from $2.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $21.5 million in Q4 2018 to a low of $506000.0 in Q3 2019.
• Average Cost of Revenue over 4 years is $5.6 million, with a median of $3.8 million recorded in 2017.
• Year-over-year, Cost of Revenue jumped 390.96% in 2018 and sank 91.86% in 2020.
• Over 4 years, Cost of Revenue stood at $9.0 million in 2017, then surged by 138.9% to $21.5 million in 2018, then sank by 48.69% to $11.0 million in 2019, then slumped by 91.86% to $897000.0 in 2020.
• Per Business Quant data, the three most recent Cost of Revenue figures were $897000.0 in Q4 2020, $2.2 million in Q1 2020, and $11.0 million in Q4 2019.